BIODESIX INC Balance Sheet
BDSX|6 years of annual SEC 10-K data (FY2020-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$87M
FY2025
Cash
$19M
Cash and equivalents
Total Debt
$50M
FY2025
Shareholder Equity
-$2M
FY2025
BIODESIX INC had $87M in total assets with negative shareholders' equity of $2M as of FY2025. Total debt was $50M against $19M in cash, resulting in $31M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -4.69 (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $19.0M | $26.2M | $26.3M | $43.1M | $32.7M | $62.1M |
| Accounts Receivable | $9.0M | $8.6M | $7.7M | $5.1M | $3.7M | $15.3M |
| Current Assets | $32.5M | $39.5M | $39.7M | $53.3M | $43.6M | $86.1M |
| PP&E (Net) | $24.8M | $27.8M | $27.9M | $5.8M | $4.2M | $3.2M |
| Goodwill | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M |
| Total Assets | $87.5M | $97.2M | $99.1M | $92.9M | $76.1M | $121.1M |
| Current Liabilities | $17.4M | $14.3M | $33.4M | $22.8M | $29.0M | $32.1M |
| Total Debt | $50.0M | $40.0M | $40.1M | $30.1M | $10.1M | $28.1M |
| Shareholders' Equity | -$2.5M | $20.9M | $4.6M | $20.6M | $19.7M | $41.2M |